(Q41576208)

4 October 2017

Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis (English)

1 reference

4 October 2017

1 reference

1 reference

Scott MA

1

1 reference

4 October 2017

Lagios MD

2

1 reference

4 October 2017

Axelsson K

3

1 reference

4 October 2017

Rogers LW

4

1 reference

4 October 2017

Anderson TJ

5

1 reference

4 October 2017

Page DL

6

1 reference

4 October 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

4 October 2017

1 reference

4 October 2017

28

1 reference

4 October 2017

967-973

1 reference

4 October 2017

8

1 reference

One century of mammary carcinoma in situ. What have we learned?

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

Intraductal carcinoma of the breast: Follow-up after biopsy only

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

ABC of breast diseases. Carcinoma in situ and patients at high risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

Duct carcinoma in situ: 227 cases without microinvasion

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

Ductal carcinoma in situ of the breast with apocrine cytology: definition of a borderline category

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

Prognostic classification of breast ductal carcinoma-in-situ

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 Trial. Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

Heterogeneity of intraductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

Duct carcinoma in situ. Pathology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990013-7

7 January 2021

10.1016/S0046-8177(97)90013-7

Identifiers

DOI

1 reference

4 October 2017

1 reference